Asian Insight Provider - Actionable ideas, CrossASEAN Research

Henry Soediarko

Asian Insight Provider - Actionable ideas

CrossASEAN Research

At CrossASEAN Research we strive to produce unbiased and differentiated on the ground insights on companies across South East Asia. Our Research is produced for the most part after face to face meetings and conversations with company management to dig deep into the long term vision and strategy of the companies we cover. We seek to deliver investable and actionable themes on sectors and markets across SE Asia, often in collaboration with other Insight Providers across the region, pooling the vast experience of the analysts within the Smartkarma Ecosystem. We also offer bespoke work and tailor made trips for our clients. 

Insights across South East Asia

Equity Bottom-Up

<a href="https://www.smartkarma.com/entities/china-feihe-ltd" target="_blank" data-smartkarma-citation="entities:24413:1" rel="noopener">China Feihe (6186 HK)</a> may have outperformed <a href="https://www.smartkarma.com/entities/health-and-happiness-h-h-int" target="_blank" data-smartkarma-citation="entities:20582:1" rel="noopener">Health And Happiness (H&amp;H) (1112 HK)</a> but the pair trade of long <a href="https://www.smartkarma.com/entities/yuanshengtai-dairy-farm-ltd" target="_blank" data-smartkarma-citation="entities:17091:1" rel="noopener">Yuanshengtai Dairy Farm (1431 HK)</a> and short <a href="https://www.smartkarma.com/entities/china-feihe-ltd" target="_blank" data-smartkarma-citation="entities:24413:1" rel="noopener">China Feihe (6186 HK)</a> have made 42% since the initiation in <a href="https://www.smartkarma.com/insights/china-feihe-6186-flying-no-more" target="_blank" data-smartkarma-citation="insights:39842" rel="noopener">China Feihe (6186): Flying No More?</a> .
The recent news that China Feihe is buying out YST has effectively collapsed the previously available valuation gap therefore it is time to also close the trade by selling YST and buy-to-cover China Feihe. 
<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/157/619/original/image_10140919521599523419732.png?1599523420" class="editor-image img-responsive" data-smartkarma-image-id="157619"></figure>

China Feihe (6186 HK) may have outperformed Health And Happiness (H&amp;H) (1112 HK) but the pair trade of long Yuanshengtai Dairy Farm (1431 HK) and short China Feihe (6186 HK) have made 42% since the initiation in China Feihe (6186): Flying No More? .
The recent news that China Feihe is buying out YST has effectively collapsed the previously available valuation gap therefore it is time to also close the trade by selling YST and buy-to-cover China Feihe. 


YST (1431) VS China Feihe (6186): Time to Close

IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Event-Driven

<a href="https://www.smartkarma.com/entities/yuanshengtai-dairy-farm-ltd" target="_blank" data-smartkarma-citation="entities:17091:1" rel="noopener">Yuanshengtai Dairy Farm (1431 HK)</a>/YST Diary is one of the leading dairy farming companies in China as measured by herd size and production volume. YST has six dairy farms in Heilongjiang Province and one dairy farm in Jilin Province. On Sunday, <a href="https://www.smartkarma.com/entities/china-feihe-ltd" target="_blank" data-smartkarma-citation="entities:24413:1" rel="noopener">China Feihe (6186 HK)</a> announced a conditional voluntary general offer to acquire all the YST shares at HK$0.63 in cash per share. The offer is conditional on the offeror and its concert parties holding at least 50% of the voting rights. The offeror and its concert parties currently hold 0.13% of the outstanding shares and have not received irrecovables. <div class="content-highlight">The offer is unlikely to see shareholders clamouring to accept the offer as the shares are up 110% YTD and the offer is a marginal 1.6% premium to the share price on the last trading date (3 September). China Feihe is YST’s largest customer and the offer is largely defensive move to limit <a href="https://www.smartkarma.com/entities/china-mengniu-dairy-co" target="_blank" data-smartkarma-citation="entities:354:1" rel="noopener">China Mengniu Dairy Co (2319 HK)</a>’s growing importance to YST, in our view. China Feihe’s offer price is final and there is a good chance the offer could fail due to the small premium. However, several of China Feihe’s peers including Mengniu have invested in raw milk suppliers to secure sufficient supply. Consequently, we would be inclined to have a long position as there is some chance that China Feihe’s bid could force out rival bidders.  </div>

Yuanshengtai Dairy Farm (1431 HK)/YST Diary is one of the leading dairy farming companies in China as measured by herd size and production volume. YST has six dairy farms in Heilongjiang Province and one dairy farm in Jilin Province. On Sunday, China Feihe (6186 HK) announced a conditional voluntary general offer to acquire all the YST shares at HK$0.63 in cash per share. The offer is conditional on the offeror and its concert parties holding at least 50% of the voting rights. The offeror and its concert parties currently hold 0.13% of the outstanding shares and have not received irrecovables. The offer is unlikely to see shareholders clamouring to accept the offer as the shares are up 110% YTD and the offer is a marginal 1.6% premium to the share price on the last trading date (3 September). China Feihe is YST’s largest customer and the offer is largely defensive move to limit China Mengniu Dairy Co (2319 HK)’s growing importance to YST, in our view. China Feihe’s offer price is final and there is a good chance the offer could fail due to the small premium. However, several of China Feihe’s peers including Mengniu have invested in raw milk suppliers to secure sufficient supply. Consequently, we would be inclined to have a long position as there is some chance that China Feihe’s bid could force out rival bidders.  

Chine Feihe Lobs a Conditional Voluntary Offer for YST Dairy

<a href="https://www.smartkarma.com/entities/china-feihe" target="_blank" data-smartkarma-citation="entities:24413:1" rel="noopener">China Feihe (FEIHE HK)</a> is the leading player in the China IMF (infant milk formula) market as measured by retail sales value in 2018, according to Frost &amp; Sullivan. It is backed by Morgan Stanley Private Equity Asia, which is a 21.7% shareholder. Feihe is set to start pre-marketing for a Hong Kong IPO to raise a potential $1 billion, according to press reports. <div class="content-highlight">In <a href="https://www.smartkarma.com/insights/china-feihe-ipo-preview-the-winning-formula" target="_blank" rel="noopener">our initiation note</a>, we stated that the Feihe’s equity story offers more positives than negatives, and we would place it on our must-look IPO watchlist. The PHIP which discloses 2Q19 metrics reinforces this view.</div>

China Feihe (FEIHE HK) is the leading player in the China IMF (infant milk formula) market as measured by retail sales value in 2018, according to Frost &amp; Sullivan. It is backed by Morgan Stanley Private Equity Asia, which is a 21.7% shareholder. Feihe is set to start pre-marketing for a Hong Kong IPO to raise a potential $1 billion, according to press reports. In our initiation note, we stated that the Feihe’s equity story offers more positives than negatives, and we would place it on our must-look IPO watchlist. The PHIP which discloses 2Q19 metrics reinforces this view.

<a href="https://www.smartkarma.com/entities/health-and-happiness-h-h-int" target="_blank" data-smartkarma-citation="entities:20582:1" rel="noopener">Health And Happiness (H&amp;H) (1112 HK)</a> 1H 2019 result was better than its Australian competitor, Bellamy, whose product is perceived to be premium in China yet it is still trading at a 77% discount at 16x PER. Post the 100 days clean up operation in China that target the health supplement industry that contributes to 35% of the company's total revenue,  its share price weakened by circa  30%; creating a buying opportunity for investors with appetite for infant milk formula cum adult nutrition care business in China.

Health And Happiness (H&amp;H) (1112 HK) 1H 2019 result was better than its Australian competitor, Bellamy, whose product is perceived to be premium in China yet it is still trading at a 77% discount at 16x PER. Post the 100 days clean up operation in China that target the health supplement industry that contributes to 35% of the company's total revenue,  its share price weakened by circa  30%; creating a buying opportunity for investors with appetite for infant milk formula cum adult nutrition care business in China.  

Health & Happiness (1112): Buy - Unjustly Punished!

Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by our proprietary data engine. We will discuss the stocks that experienced the most inflow and outflow by mainland investors in the past seven days.We split the stocks eligible for the Hong Kong Connect trade into three groups: component stocks in the HSCEI index, stocks with a market capitalization between USD 1 billion and USD 5 billion, and stocks with a market capitalization between USD 500 million and USD 1 billion.In this insight, we will highlight Air China and Great Wall Motor.

In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by our proprietary data engine. We will discuss the stocks that experienced the most inflow and outflow by mainland investors in the past seven days.We split the stocks eligible for the Hong Kong Connect trade into three groups: component stocks in the HSCEI index, stocks with a market capitalization between USD 1 billion and USD 5 billion, and stocks with a market capitalization between USD 500 million and USD 1 billion.In this insight, we will highlight Air China and Great Wall Motor. 

HK Connect Discovery Weekly: Air China and Great Wall Motor (2019-04-04)

China

China Modern Dairy is a leading dairy farming operator and raw milk producer in China. The company also engages in the production and sale of animal feed, forage cultivation, dairy cow breeding, and provides digital intelligence platform services. It was founded in 2005 and is headquartered in Ma'anshan City, Anhui Province, China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

China Modern Dairy (1117 HK)

YST (1431) VS China Feihe (6186): Time to Close

China Feihe (6186 HK) may have outperformed Health And Happiness (H&H) (1112 HK) but the pair trade of long Yuanshengtai Dairy Farm (1431 HK)...

Henry Soediarko

Chine Feihe Lobs a Conditional Voluntary Offer for YST Dairy

$ is the one of the leading dairy farming companies in China as measured by herd size and production volume. YST has six dairy farms in...

Arun George

China Feihe IPO: Uncowed

China Feihe (FEIHE HK) is the leading player in the China IMF (infant milk formula) market as measured by retail sales value in 2018, according to...

Arun George

Health & Happiness (1112): Buy - Unjustly Punished!

Health And Happiness (H&H) (1112 HK) 1H 2019 result was better than its Australian competitor, Bellamy, whose product is perceived to be...

Henry Soediarko

HK Connect Discovery Weekly: Air China and Great Wall Motor (2019-04-04)

In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)